...

Executive Summary

A practical guide for foreign medical device manufacturers on FDA establishment registration, device listing, US Agent duties, annual fees, and the renewal window.

A shipment of operating tables sits in a bonded warehouse in New Jersey, cleared by customs but blocked by the importer. The reason has nothing to do with the product itself. The factory that built them never completed its FDA establishment registration, so the device listing behind the purchase order is invalid, and the U.S. distributor cannot legally place the goods into commercial distribution. Weeks of demurrage charges pile up while a compliance team on the other side of the Pacific scrambles to fix a record that should have been settled months earlier.

If you manufacture medical devices outside the United States and sell them into the U.S. market, this scenario is not hypothetical. Foreign establishment registration and device listing under 21 CFR Part 807 is one of the most frequently mishandled steps in the entire export chain. It is also one of the easiest to get right once you understand the mechanics. The registration itself is not a quality certificate and it does not mean the FDA has approved your device. It is a mandatory administrative record that tells the agency who made a product, where it was made, and which U.S. party can be reached when questions arise.

In this guide I will walk through the full workflow the way it actually plays out for overseas factories, with particular attention to how a Chinese manufacturer and its U.S. partners should divide the work. If you are still mapping out the broader regulatory picture, our companion piece on CE MDR vs FDA for equipment import explains how the European and American routes differ before you ever reach the registration step. Let’s focus here on the specific obligations that fall on a foreign establishment.

Sanyang Medical Abs Emergency Trolley Factory Photo Foxtrot
A finished-device staging area inside a registered foreign manufacturing facility. Every product family shipped to the U.S. must trace back to a valid device listing.

What FDA Establishment Registration Actually Means for a Foreign Manufacturer

Establishment registration is the FDA’s mechanism for knowing which facilities are involved in producing and distributing medical devices intended for commercial use in the United States. For a domestic company this is straightforward. For a foreign manufacturer it carries an extra layer of obligation, because the agency needs a reliable domestic point of contact and a clear chain of accountability across the border.

Two distinct but linked actions are involved, and confusing them is the source of half the problems I see:

  • Establishment registration records the facility itself: the legal name, the physical address, the type of operation performed there (manufacturer, contract sterilizer, repackager, specification developer, and so on), and the assigned U.S. Agent.
  • Device listing records each device marketed in the U.S. and links it to the establishment that produced it, along with the applicable product code, the device class, and any required premarket submission number such as a 510(k) or PMA.

A factory can be perfectly registered and still have no valid listing for the specific product on a purchase order, and the reverse is also true. Both records must be current and consistent for a shipment to move cleanly. The governing rules live in 21 CFR Part 807, with Section 807.40 spelling out the additional duties that apply specifically to foreign establishments importing or offering devices for import into the United States.

Registration is not approval. The FDA states plainly that registering a device establishment does not denote approval or clearance of the establishment or its devices. Treat registration as the administrative floor that lets you operate legally, never as a marketing claim.

Who Must Register: Mapping Your Establishments Under 21 CFR Part 807

The first practical task is figuring out which of your facilities and which of your partners actually trigger a registration obligation. Section 807.20 sets out who must register and submit a device list, and the definition is broader than most manufacturers expect. It is not only the final assembly plant.

Any establishment engaged in the production or distribution of a device intended for human use in the U.S. generally needs to register unless a specific exemption applies. For a foreign supply chain that typically means several distinct entities:

  • The foreign manufacturer that performs the production steps on the device, whether that is full build or a defined manufacturing operation.
  • A contract sterilizer if sterilization is performed at a separate site, which is common for sterile single-use components.
  • A specification developer or private-label owner that owns the device design and branding even if it never touches the product physically.
  • The initial importer in the United States, which has its own registration and listing duties separate from the foreign factory.

This is where coordination matters. A hospital furniture and equipment program, for example, may involve a frame fabricator, a final assembler, and a separate sterilization vendor. Each site that performs a covered operation should be evaluated for registration. When we build out a product line such as our operating tables, we map every covered establishment early so that a last-minute subcontractor does not create an unregistered link in the chain.

Sanyang Medical ABS Patient Trolley Hospital Bed Factory Photo Charlie
Production lines for patient transport equipment. Each covered manufacturing site in the supply chain may carry its own registration obligation.

The US Agent: Your Mandatory Domestic Lifeline

Every foreign establishment that manufactures, prepares, propagates, compounds, or processes a device imported into the United States must designate a U.S. Agent. This is not an optional formality. The agent is the FDA’s guaranteed point of contact on American soil, and the agency will reach out to that party when it needs information, wants to schedule an inspection, or has a question about an imported shipment.

The U.S. Agent must reside in the United States or maintain a place of business there, and must be physically present and reachable. A post office box or an answering service that never picks up will not satisfy the requirement in practice, even if it technically fills the form field. The agent’s responsibilities include:

  • Responding to FDA communications concerning the foreign establishment’s imported products.
  • Assisting the agency in scheduling and coordinating inspections of the foreign site.
  • Providing or helping obtain documents the FDA requests when the foreign manufacturer cannot respond quickly enough on its own.

A common mistake is naming a freight forwarder or a customs broker who has no real regulatory capacity and then discovering, during a time-sensitive inquiry, that nobody is answering. Choose an agent who understands device regulation and who has a documented process for escalating FDA contact to your quality team within a defined window. The agent relationship should be written into your quality agreements so that responsibilities and response times are explicit.

Pick a U.S. Agent the way you would pick an emergency contact, not the way you pick a mailing address. When the FDA calls, the speed and competence of that response can determine whether a shipment clears or a facility falls out of good standing.

Step-by-Step: The Foreign Establishment Registration and Device Listing Workflow

Registration and listing are completed electronically through the FDA’s unified system, commonly referred to as FURLS, with device work handled in the Device Registration and Listing Module (DRLM). The sequence below reflects how the process actually unfolds for a foreign factory preparing to ship into the U.S. for the first time.

Step 1: Confirm Your Pre-market Foundation

Before you register, confirm that the device itself has the premarket basis it needs. A Class II device that requires a 510(k) must have a cleared submission, and a Class III device must have an approved PMA, before the listing can be completed correctly. Registration does not substitute for clearance or approval. This is also the moment to verify the correct product code and device class, because those fields drive everything downstream. If your device sits in a category we manufacture heavily, such as surgical lights, the product code and class should be confirmed against the FDA’s product classification database before you touch the listing form.

Step 2: Obtain Your Facility Identifier and Create the Account

Each establishment is associated with a unique facility identifier in the system. You will create an account, enter the legal entity details exactly as they appear on your official registration documents, and provide the physical site address. Consistency of the legal name and address across your business license, your quality certificates, and the FDA record is essential. Mismatched entity names are a frequent cause of delays when an importer or the FDA tries to reconcile records.

Step 3: Register the Establishment and Assign the US Agent

With the account in place, you register the establishment, select the operation types performed at the site, and assign the U.S. Agent. The agent will typically receive a notification to confirm the association. Do not consider the assignment complete until that confirmation has been recorded in the system.

Step 4: Pay the Annual Establishment Registration Fee

Effective October 1, 2012, all establishments required to register must pay the user fee before completing registration. For Fiscal Year 2026, which runs from October 1, 2025 through September 30, 2026, the FDA’s published annual establishment registration fee is $11,423. The fee is set each fiscal year under the Medical Device User Fee Amendments (MDUFA), so always confirm the current figure on the FDA’s fee page before budgeting. Certain small businesses that qualify through the Small Business Determination program may be eligible for a waiver of the annual fee in cases of demonstrated financial hardship, but this must be established through the proper channel and does not apply automatically.

Step 5: List Each Device

Finally, you list each device, linking it to the registered establishment and entering the product code, device class, and any premarket submission number. Each product family that you intend to market in the U.S. needs its own listing entry. A single registration with no listings, or listings that do not match what is actually being shipped, leaves you exposed at the border.

Sanyang Medical Medical Pendant Factory Photo Delta
Medical pendant assembly at a registered facility. Each product family marketed in the U.S. requires its own device listing entry tied to the establishment.

Fees, Timing, and the Annual Renewal Window

Timing is where foreign manufacturers most often trip. Initial registration is due within a defined period after a covered establishment begins operations, but the recurring obligation that catches people off guard is the annual re-registration. Each year, establishments must re-register and renew their device listings during a fixed window that runs from October 1 through December 31. Miss that window and the registration can lapse, which in turn invalidates the device listings that depend on it.

The table below summarizes the key obligations and their timing for a foreign establishment. Treat the fee figure as the FY2026 value and reconfirm annually, since MDUFA fees are adjusted each fiscal year.

Obligation When It Applies Key Detail
Initial establishment registration Within the required period after beginning covered operations Register the facility and assign a U.S. Agent before importing
Device listing Before commercial distribution of each device Link product code, class, and 510(k)/PMA number to the establishment
Annual establishment registration fee Each fiscal year, paid before registration is completed $11,423 for FY2026; reconfirm each year on the FDA fee page
Annual re-registration and listing renewal October 1 through December 31, every year Review all facility information and renew every associated listing
Update on material change Within the required period after a change Changes to name, address, U.S. Agent, or operation type must be updated

I recommend treating the October-to-December window as a hard internal deadline rather than a suggestion. Build a recurring calendar task into your regulatory affairs process so that re-registration is completed in October, not scrambled through on December 30. A lapsed registration can halt shipments at the worst possible moment, and reinstating good standing takes longer than simply staying current.

Coordinating With Your Chinese Factory: A Practical Division of Labor

For many U.S. distributors and OEM partners, the device is built by a Chinese manufacturer while the commercial and regulatory interface sits in the United States. This split works well when responsibilities are clearly assigned, and it breaks down when both sides assume the other is handling the FDA record. A clean division of labor looks something like this.

  • The foreign manufacturer owns the establishment registration for its production sites, maintains accurate legal-entity and address data, performs the device listings for the products it builds, and keeps the technical documentation that supports those listings.
  • The U.S. Agent serves as the domestic point of contact, relays FDA communications promptly, and supports inspection scheduling.
  • The U.S. importer or specification developer handles its own initial-importer registration and confirms that the foreign factory’s registration and the relevant device listings are valid before placing goods into distribution.

This is precisely the kind of structured collaboration that makes an OEM or ODM partnership viable across borders. When we work with partners on localized programs through our OEM/ODM localization service, the regulatory handoff points are defined up front: who registers which establishment, who owns each device listing, and who confirms validity before every container ships. Putting this in writing at the start of the relationship prevents the finger-pointing that happens when a shipment is held.

Sanyang Medical Surgical Light Factory Photo Bravo
Surgical light production at a Chinese manufacturing facility serving U.S.-bound OEM programs, where registration and listing duties are split between factory and importer.

How US Importers Verify Your Registration (and Why It Matters)

A responsible U.S. importer does not take a factory’s word for its registration status. The FDA maintains a public Establishment Registration and Device Listing database that anyone can search to confirm whether a manufacturer is registered and whether a specific device is listed. Savvy importers check this database before issuing a purchase order and again before each shipment, because a registration that was valid in January can lapse by March if the annual renewal was missed.

Verification typically involves confirming several data points against the official record:

  • That the establishment name and address on the purchase order match the registered entity exactly.
  • That the registration is current and has not expired or been deactivated.
  • That the specific device, by product code and listing, appears under that establishment.
  • That any required premarket number associated with the listing is valid.

This verification discipline is part of a broader compliance habit. Importers who already verify quality certificates and traceability documents will find the registration check fits naturally into the same routine. Our guide on how to verify ISO and CE certifications covers the same skeptical, trust-but-confirm mindset that should be applied to FDA registration records. Pairing the registration check with accurate customs documentation, as described in our medical device HS codes and customs guide, gives a shipment the best chance of clearing without delay.

The FDA database is public for a reason. If your importer can find a problem in thirty seconds of searching, so can a customs officer. Make sure the record they find is current, consistent, and complete before the goods ever leave the port.

Common Mistakes That Fail Verification

Across the projects I have been involved with, the same handful of errors accounts for the majority of the problems an importer’s verification check will uncover. None of them are technically difficult to avoid; they fail because of process gaps rather than regulatory complexity.

  • Missing the annual renewal window. Letting registration lapse between October and December silently invalidates dependent listings.
  • Entity-name mismatches. The legal name on the FDA record differs from the business license or the certificate, breaking the traceability chain.
  • An absent or unresponsive U.S. Agent. A named agent that cannot be reached defeats the purpose of the requirement.
  • Listing the wrong product code or class. A device listed under an incorrect code may not match what is physically shipped.
  • Registering the final assembler but not a covered subcontractor. An unregistered sterilization or manufacturing site leaves a gap in the chain.
  • Failing to update after a material change. A factory move, a name change, or a new agent that is never reported leaves the record stale.

The antidote to all of these is a single owner inside your organization who treats the FDA record as a living document. Assign one person in regulatory affairs to maintain the registration, schedule the annual renewal, and reconcile the listings against the active product catalog at least twice a year. When that ownership exists, registration stops being a source of risk and becomes a routine background task.

Sanyang Medical Surgical Light Factory Photo India
Final inspection of surgical lighting systems. A disciplined internal owner of the FDA record keeps registration and listings reconciled against the active product catalog.

Conclusion

FDA establishment registration for foreign manufacturers is best understood as the administrative foundation that makes everything else possible. It does not certify quality and it does not approve your device, but without a current registration and accurate device listings, a foreign factory cannot legally place products into U.S. distribution, and its shipments are vulnerable at the border. The mechanics are governed by 21 CFR Part 807, completed electronically through the FDA’s FURLS system, and anchored by a U.S. Agent who must be genuinely reachable.

The manufacturers and importers who handle this well share a few habits. They confirm the premarket basis before listing, they pay the annual fee and complete re-registration early in the October-to-December window, they keep legal-entity data consistent across every document, and they assign clear ownership of the FDA record to a single responsible person. For Chinese factories serving U.S. partners, the additional discipline is a written division of labor that defines who registers which establishment and who verifies validity before each shipment.

If you are building or expanding a U.S.-bound device program and want a manufacturing partner that already operates within a disciplined compliance framework, it is worth reviewing how an experienced OEM structures these obligations from day one. You can learn more about our capabilities on our about us page, and if you have a specific program in mind, contact us to discuss how registration, listing, and the supporting documentation fit into your project timeline.

Frequently Asked Questions

Does FDA establishment registration mean my device is approved?

No. Registration records the establishment and its role in producing a device; it is not a marketing authorization. The FDA explicitly notes that registering a device establishment does not denote approval of the establishment or its devices. Clearance or approval comes through the appropriate premarket pathway, such as a 510(k) or PMA, depending on the device class.

Who is required to act as the US Agent for a foreign establishment?

The U.S. Agent must be a person or entity that resides in or maintains a place of business in the United States and is physically reachable. The agent acts as the FDA’s domestic point of contact for communications and inspection scheduling. Choose an agent with genuine regulatory capacity and a documented escalation process, not merely a mailing address.

How much does foreign establishment registration cost, and when is it due?

Most establishments must pay an annual establishment registration fee before completing registration. For Fiscal Year 2026 the FDA’s published fee is $11,423, and the amount is adjusted each fiscal year under MDUFA, so always confirm the current figure on the FDA fee page. Certain qualifying small businesses may be eligible for a fee waiver through the Small Business Determination program in cases of financial hardship.

When must a foreign establishment re-register each year?

Annual re-registration and device listing renewal take place during a fixed window from October 1 through December 31 each year. During this period the establishment reviews all of its facility information and renews every associated device listing. Missing the window can cause the registration to lapse and invalidate dependent listings.

How can a US importer verify that a foreign manufacturer is properly registered?

The FDA maintains a public Establishment Registration and Device Listing database that importers can search to confirm an establishment’s registration status and to verify that a specific device is listed under it. Importers should confirm that the entity name and address match, that the registration is current, and that the relevant device listing and any premarket number are valid before placing goods into distribution.

Leave a Comment

Back to top
Need a fast quotation? Chat with our export team on WhatsApp.